Loading data
CRAINasdaq
| Unit: USD | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 751.58 m USD | 687.41 m USD | 623.98 m USD | 590.9 m USD | 565.93 m USD |
| Selling, general and administrative expense | 135.03 m USD | 125.05 m USD | 115.12 m USD | 110.09 m USD | 97.37 m USD |
| Operating profit | 83.12 m USD | 70.75 m USD | 57.55 m USD | 58.74 m USD | 55.74 m USD |
| Interest expense | — | — | 3.81 m USD | 1.83 m USD | 970 k USD |
| Profit before tax | 76.57 m USD | 66.24 m USD | 52.29 m USD | 58.8 m USD | 54.28 m USD |
| Income tax expense | 21.79 m USD | 19.59 m USD | 13.81 m USD | 15.18 m USD | 12.6 m USD |
| Net income (reported basis) | 54.8 m USD | 46.7 m USD | 38.5 m USD | 43.6 m USD | 41.7 m USD |
| Net income attributable to common shareholders | 54.78 m USD | 46.65 m USD | 38.48 m USD | 43.62 m USD | 41.68 m USD |
| Basic earnings per share | 8.23 USD/share | 6.82 USD/share | 5.48 USD/share | 6.02 USD/share | 5.59 USD/share |
| Diluted earnings per share | 8.14 USD/share | 6.74 USD/share | 5.39 USD/share | 5.91 USD/share | 5.45 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.